The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
Abstract
The phenomenon of enhanced glycolysis in tumours has been acknowledged for decades, but biochemical evidence to explain it is only just beginning to emerge. A significant hint as to the triggers and advantages of enhanced glycolysis in tumours was supplied by the recent discovery that succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tumour suppressors and which associated, for the first time, mitochondrial enzymes and their dysfunction with tumorigenesis. Further steps forward showed that the substrates of SDH and FH, succinate and fumarate, respectively, can mediate a 'metabolic signalling' pathway. Succinate or fumarate, which accumulate in mitochondria owing to the inactivation of SDH or FH, leak out to the cytosol, where they inhibit a family of prolyl hydroxylase enzymes (PHDs). Depending on the PHD inhibited, two newly recognized pathways that support tumour maintenance may ensue: affected cells become resistant to certain apoptotic signals and/or activate a pseudohypoxic response that enhances glycolysis and is conveyed by hypoxia-inducible factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In animal models, fumarate hydratase inactivation induces a precancerous phenotype associated with chronic HIF pathway activation, highlighting the intersection of mitochondrial metabolism, redox homeostasis, and HIF regulation [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“These metabolic perturbations, which are tightly linked to altered cellular redox balance, result in pseudohypoxic signaling and increased cancer susceptibility [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“Mitochondrial dysfunction could impair oxidative phosphorylation, the TCA cycle, fatty acid oxidation, the urea cycle, gluconeogenesis, and apoptotic pathways (King et al., 2006; Modica-Napolitano and Singh, 2004).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as King et al., 2006
In the citing paper
“Loss-of-function mutations in SDH and FH cause a build-up of succinate and fumarate, respectively87. Accordingly, increased levels of succinate and fumarate caused by mutations in these genes can compete with αKG and inhibit activity of HIF hydroxylases and thus induce normoxic HIF1α activity in vitro88,89.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [87]
In the citing paper
“Interestingly, inherited mutations in fumarate hydratase, another Krebs cycle enzyme, have also been linked to a separate and equally rare inherited cancer syndrome 96 .”
From The common biology of cancer and ageing (2007) · cites this paper as [96]
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 4×
“Although both molecules were shown to mediate HIF induction (Isaacs et al., 2005; Selak et al., 2005), it is possible that they inhibit different PHDs with different efficiency.”
BackgroundInfluentialSelf-citationOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Moreover, enhanced glucose breakdown provides building blocks for the synthesis of nucleotides (via the pentose phosphate pathway), and amino and fatty acids (from glycolytic and TCA cycle intermediates) (Figure 1) (Owen et al., 2002).”
BackgroundOncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 1×
“These are reactive oxygen species (ROS), which can be generated by the ETC, especially in complex I and III (Raha and Robinson, 2000).”
BackgroundDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K. (2004) · Nature Genetics · doi:10.1038/ng1494 · Cited by 980
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 674
Melatonin and its mechanism of action in the female reproductive system and related malignancies
Ezzati, M., Velaei, K., & Kheirjou, R. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04151-z · Cited by 19
Yaneske, E., Zampieri, G., Bertoldi, L., Benvenuto, G., & Angione, C. (2021) · FEBS Letters · doi:10.1002/1873-3468.14180 · Cited by 19
Cell-Mediated Immunity in Cervical Cancer Evolution
Jandová, A., Pokorný, J., Kobilková, J., Janoušek, M., Mašata, J., Trojan, S., Nedbalová, M., Dohnalova, A., Beková, A., Slavík, V., et al. (2009) · Electromagnetic Biology and Medicine · doi:10.1080/15368370802708868 · Cited by 19
Wang, Y., Liu, B., Li, F., Zhang, Y., Gao, X., Wang, Y., & Zhou, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1274239 · Cited by 18
Unraveling the nexus: Genomic instability and metabolism in cancer
Gujar, V. V., Li, H., Paull, T. T., Neumann, C. A., & Weyemi, U. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115540 · Cited by 21
Is nuclear sirtuin SIRT6 a master regulator of immune function?
Pillai, V. B., & Gupta, M. P. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00483.2020 · Cited by 18
Abushawish, K. Y. I., Soliman, S. S. M., Giddey, A. D., Al-Hroub, H. M., Mousa, M., Alzoubi, K. H., El‐Huneidi, W., Abu‐Gharbieh, E., Omar, H. A., Elgendy, S. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911975 · Cited by 19
Potassium Channels, Glucose Metabolism and Glycosylation in Cancer Cells
Wawrzkiewicz–Jałowiecka, A., Lalik, A., Łukasiak, A., Richter-Laskowska, M., Trybek, P., Ejfler, M., Opałka, M., Wardejn, S., & Delfino, D. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097942 · Cited by 18
Malayil, R., Chhichholiya, Y., Vasudeva, K., Singh, H. V., Singh, T., Singh, S., & Munshi, A. (2023) · Medical Oncology · doi:10.1007/s12032-023-02037-2 · Cited by 19
Mishra, E., & Thakur, M. K. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109536 · Cited by 20
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
Fitzsimmons, C. M., Mandler, M. D., Lunger, J. C., Chan, D., Maligireddy, S. S., Schmiechen, A. C., Gamage, S. T., Link, C. N., Jenkins, L. M. M., Chan, K. C., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcae004 · Cited by 18
Zhang, X., Qian, S., Wu, P., Yu, B., Yin, D., Xia, P., Li, S., Xiao, Z., & Xie, Z. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01799-0 · Cited by 19
Metabolic reprogramming in cancer: mechanistic insights from Drosophila
Wong, K. K. L., & Verheyen, E. M. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048934 · Cited by 20
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites
Lee, J. H., Mosher, E. P., Lee, Y., Bumpus, N. N., & Berger, J. M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.08.014 · Cited by 18
Khan, A. A., Khan, Z., Malik, A., Shrivastava, A., Jain, S. K., & Alshamsan, A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.024 · Cited by 18
Li, W., & Zhao, Y. (2012) · Cancer Science · doi:10.1111/cas.12051 · Cited by 18
Kuang, P., Zhou, C., Li, X., Ren, S., Li, B., Wang, Y., Li, J., Tang, L., Zhang, J., & Zhao, Y. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.016 · Cited by 18
Lee, C., Chen, Y., Wang, P., Wallace, D. C., & Burke, P. J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03244 · Cited by 16
Germanova, E. L., Khmil, N. V., Pavlik, L. L., Mikheeva, I. B., Mironova, G. D., & Lukyanova, L. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214248 · Cited by 17
Tumour metabolites hinder DNA repair
Chen, L., & Xiong, Y. (2020) · Nature · doi:10.1038/d41586-020-01569-1 · Cited by 17
Lv, W., Tang, D., Shen, C., Bai, Y., Jiang, K., Qian, Y., & Wang, Z. (2021) · Genomics · doi:10.1016/j.ygeno.2021.03.010 · Cited by 17
Intracellular Succinylation of 8-Chloroadenosine and Its Effect on Fumarate Levels
Dennison, J. B., Ayres, M., Kaluarachchi, K. K., Plunkett, W. K., & Gandhi, V. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085803 · Cited by 17
Yang, Y., Wang, Y., Wang, Z., Yan, H., Gong, Y., Hu, Y., Jiang, Y., Wen, S., Xu, F., Wang, B., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01351-9 · Cited by 18
Zhao, L., Guo, J., Xu, S., Duan, M., Liu, B., Zhao, H., Wang, Y., Liu, H., Yang, Z., Yuan, H., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.016 · Cited by 18
Jiang, Z., Wang, X., Rastrick, S. P. S., Fang, J., Du, M., Gao, Y., Li, F., Strand, Ø., & Fang, J. (2019) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2019.01.003 · Cited by 15
Novel Hereditary Forms of Pheochromocytomas and Paragangliomas
Dahia, P. L. M. (2013) · Frontiers of hormone research · doi:10.1159/000345671 · Cited by 16
Huang, K. T., Dobrovic, A., & Fox, S. B. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-194 · Cited by 16
Li, B. J., Tian, X., Wang, C., Zeng, X., Xing, Y.-M., Ling, H., Yin, W., Tian, L., Meng, Z.-X., Zhang, J., et al. (2017) · Scientific Reports · doi:10.1038/srep41283 · Cited by 16
Ueno, D., Vasquez, J. C., Sule, A. D., Liang, J., Doorn, J. V., Sundaram, R. K., Friedman, S., Caliliw, R., Ohtake, S., Bao, X., et al. (2022) · Oncotarget · doi:10.18632/oncotarget.28273 · Cited by 15
Catalano, F., Cremante, M., Dalmasso, B., Pirrone, C., D’Amato, A. L., Grassi, M., & Comandini, D. (2023) · Cancers · doi:10.3390/cancers15072074 · Cited by 16
Han, A., Peng, T., Xie, Y., Zhang, W., Sun, W., Xie, Y., Ma, Y., Wang, C., & Xie, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1301074 · Cited by 15
Priéto, I., Alarcon, C. R., García-Gómez, R., Berdún, R., Urgel, T., Portero‐Otín, M., Pamplona, R., Martı́nez-Ruiz, A., Ruiz-Sanz, J. I., Ruiz‐Larrea, M. B., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101396 · Cited by 15
Impact of metabolic stress induced by diets, aging and fasting on tissue oxygen consumption
Mackert, O., Wirth, E. K., Sun, R., Winkler, J. L., Liu, A., Renko, K., Kunz, S., Spranger, J., & Brachs, S. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101563 · Cited by 17
Kumar, A., Akhtar, A., Kuhad, A., & Sah, S. P. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06530-4 · Cited by 15
Can metabolic plasticity be a cause for cancer? Warburg–Waddington legacy revisited
Bhat, P. J., Darunte, L. A., Kareenhalli, V. V., Dandekar, J. U., & Kumar, A. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0030-x · Cited by 16
Downregulation of Fumarate Hydratase Is Related to Tumorigenesis in Sporadic Renal Cell Cancer
Ha, Y., Chihara, Y., Yoon, H.-Y., Kim, Y., Kim, T.-H., Woo, S. H., Yun, S. J., Kim, I. Y., Hirao, Y., & Kim, W. (2012) · Urologia Internationalis · doi:10.1159/000345608 · Cited by 15
Regulation and Functional Significance of 5-Hydroxymethylcytosine in Cancer
Arvinden, V. R., Rao, A. K. D. M., Rajkumar, T., & Mani, S. (2017) · Epigenomes · doi:10.3390/epigenomes1030019 · Cited by 15
A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas
Casar‐Borota, O., Øystese, K. A., Sundström, M., Melchior, L. C., & POPOVIC, V. M. (2016) · Pituitary · doi:10.1007/s11102-016-0720-7 · Cited by 14
Roh, T. H., Yim, H., Roh, J., Lee, K. B., Park, S. H., Jeong, S., Kim, S.-H., & Kim, J.-H. (2019) · Scientific Reports · doi:10.1038/s41598-019-42338-z · Cited by 14
Teng, C., Kuo, H., & Sze, C. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.07.009 · Cited by 14
Lu, J., Yang, Z., Lu, D., Xing-de, W., SHI, J.-J., Lin, T.-Q., Wang, M.-M., Li, Y., & TANG, L.-H. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.906 · Cited by 14
Doello, S., Liang, Z., Cho, I. K., Kim, J. B., & Li, Q. X. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00491 · Cited by 15
Gut Microbiome, a Potent Modulator of Epigenetics in Human Diseases
Kim, J. (2017) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2017.47.2.75 · Cited by 13
Roy, S., Das, A., Bairagi, A., Das, D., Jha, A., Srivastava, A. K., & Chatterjee, N. (2024) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2024.108490 · Cited by 13
Proteomics revisits the cancer metabolome
Hu, H., Deng, C., Yang, T., Dong, Q. G., Chen, Y., Nice, E. C., Huang, C., & Wei, Y. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.31 · Cited by 13
Zhang, H., Guo, X., Dai, J., Wu, Y., Ge, N., Yang, Y., Ji, J., & Zhang, H. (2014) · Medical Oncology · doi:10.1007/s12032-014-0278-z · Cited by 13
Zhou, Y., Yan, M.-L., Gao, L., Zhang, J., Qin, X., Zhang, X., & Du, G. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.07.020 · Cited by 13
Chen, Y., Zhong, S., Liu, S., Gao, F., Li, F., Zhao, Y., Sun, X., Miao, Y., & Wang, Z. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.022 · Cited by 13
The role of metabolomics in hepatocellular carcinoma
Khalil, A. A., Elfert, A., Ghanem, S. E., Helal, M., Abdelsattar, S., Gedawy, G. A. E., Obada, M., Abdel-Samiee, M., & El‐Said, H. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00085-9 · Cited by 12
Effects of Dietary Energy Restriction on Gene Regulation in Mammary Epithelial Cells
Zhu, Z., Jiang, W., McGinley, J. N., Price, J., Gao, B., & Thompson, H. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2834 · Cited by 13
Dong, G., He, X., Chen, Y., Cao, H., Wang, J., Liu, X., Wang, S., Wan, S., & Xing, J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0442-x · Cited by 13
Cho, S., Song, N., Choi, J., & Shin, A. (2020) · Cancers · doi:10.3390/cancers12102939 · Cited by 13
Multibiomarker assessment in zebrafish Danio rerio after the effects of malathion and chlorpyrifos
Боднар, О. І., Horyn, O., Khatib, I., & Falfushynska, H. (2021) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-021-00099-1 · Cited by 12
Vadhan, A., Yang, Y., Wang, Y., Chen, P., Tzou, S.-C., Cheng, K., Hu, S. C., Cheng, T., Wang, Y., & Yuan, S. F. (2022) · Oncology Letters · doi:10.3892/ol.2022.13627 · Cited by 12
Yamamoto, M., Tanaka, H., Toki, Y., Hatayama, M., Ito, S., Addo, L., Shindo, M., Sasaki, K., Ikuta, K., Ohtake, T., et al. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2054-7 · Cited by 12
Guo, X., Sun, Z., Jiang, S., Jin, X., & Wang, H. (2021) · Aging · doi:10.18632/aging.202636 · Cited by 12
Integration of Energy Metabolism and Control of Apoptosis in Tumor Cells
Pastorino, J. G., & Hoek, J. B. (2008) · Springer eBooks · doi:10.1007/978-0-387-84835-8_7 · Cited by 11
Li, N., Chamkha, I., Verma, G., Swoboda, S., Lindstedt, M., Greiff, L., Elmér, E., & Ehinger, J. K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1304106 · Cited by 11
Breast Cancer Risk and Management in the Endocrine Clinic: A Comprehensive Review
Hawazie, A., & Druce, M. R. (2025) · Clinical Endocrinology · doi:10.1111/cen.15209 · Cited by 11
Chen, H., Zhu, W., Li, X., Xue, L., Wang, Z., & Wu, H. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2355-0 · Cited by 11
Ferreira, C. M., Oliveira, M., Paes, M. C., & de Oliveira, M. F. (2018) · Cell Biology International · doi:10.1002/cbin.10945 · Cited by 11
Zhang, Y., Wu, N., Li, Q., Hu, X., Wang, L., Sun, J., Wang, Z., & Sun, X. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108449 · Cited by 11
BRAF-Inhibitor-Induced Metabolic Alterations in A375 Melanoma Cells
Karki, P., Sensenbach, S., Angardi, V., & Orman, M. A. (2021) · Metabolites · doi:10.3390/metabo11110777 · Cited by 13
Parthenolide targets NF-κB (P50) to inhibit HIF-1α-mediated metabolic reprogramming of HCC
Liu, X., Gao, Z., Wang, X., & Shen, Y. (2022) · Aging · doi:10.18632/aging.204339 · Cited by 11
Siebers, E. M., Choi, M. J., Tinklenberg, J. A., Beatka, M. J., Ayres, S., Meng, H., Helbling, D. C., Takizawa, A., Bennett, B., Garces, A. M., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly042 · Cited by 13
The Crucial Roles of Intermediate Metabolites in Cancer
Huang, S., Wang, Z., & Zhao, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s321433 · Cited by 11
Gandhi, S., Sethuraman, S., & Krishnan, U. M. (2013) · Macromolecular Research · doi:10.1007/s13233-013-1101-y · Cited by 11
Altered Dynamics of Intestinal Cell Maturation in Apc1638N/+ Mice
Wang, D., Pezo, R. C., Corner, G. A., Sison, C. P., LESSER, M. L., Shenoy, S. M., Mariadason, J. M., Singer, R. H., & Augenlicht, L. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4593 · Cited by 12
Cytoplasmic signaling in the control of mitochondrial uproar?
Hermann, M., Kuznetsov, A. V., Maglione, M., Smigelskaite, J., Margreiter, R., & Troppmair, J. (2008) · Cell Communication and Signaling · doi:10.1186/1478-811x-6-4 · Cited by 11
Gastrointestinal stromal tumors
Rosell, R. (2012) · doi:10.2217/ebo.12.19 · Cited by 11
Manipulating mannose metabolism as a potential anticancer strategy
Harada, Y. (2024) · FEBS Journal · doi:10.1111/febs.17230 · Cited by 10
The epigenetic–metabolic interplay in gliomagenesis
Phasaludeen, B., Emerald, B. S., & Ansari, S. A. (2022) · Open Biology · doi:10.1098/rsob.210350 · Cited by 10
Metabolic Changes in Masseter Muscle of Rats Submitted to Acute Stress Associated with Exodontia
Iyomasa, M. M., Fernandes, F. S., Iyomasa, D. M., Pereira, Y. C. L., Fernández, R. A. R., Calzzani, R. A. J., Nascimento, G. C., Leite‐Panissi, C. R. A., & Issa, J. P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128397 · Cited by 10
The Whole (Cell) Is Less Than the Sum of Its Parts
Vranken, J. G. V., & Rutter, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.08.011 · Cited by 11
Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis
Lee, W., Chou, H., Wu, T.-J., Lee, C., Hsu, P., Hsu, H.-Y., Wu, T., & Chan, K. (2017) · Clinical Proteomics · doi:10.1186/s12014-017-9164-y · Cited by 10
Wong, K. K. L., Liao, J. Z., Shih, C. R. Y., Harden, N., & Verheyen, E. M. (2020) · Journal of Cell Science · doi:10.1242/jcs.250944 · Cited by 10
Huang, M., Gu, S., Huang, B., Li, G., Xiong, Z., Tang, T., & Zeng, S. (2021) · Pharmacology · doi:10.1159/000514410 · Cited by 10
Zeng, R., Kim, H. G., Kim, N. R., Lee, H., Jung, B. J., Ko, M. Y., Lee, S. Y., & Chung, D. K. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0073-4 · Cited by 10
Zhang, M., Liu, J., Wang, W., & Bao, Y. (2018) · Journal of Soils and Sediments · doi:10.1007/s11368-018-2050-z · Cited by 9
Mitochondrial Factors in the Cell Nucleus
González‐Arzola, K., & Dı́az-Quintana, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713656 · Cited by 12
McBride, M. A., Burelbach, K. R., Patil, T. K., Owen, A. M., Luan, L., Bohannon, J. K., Hernandez, A., Stothers, C. L., Trenary, I. A., Rahim, M., et al. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae198 · Cited by 10
Proteomic Alterations in Response to Hypoxia Inducible Factor 2α in Normoxic Neuroblastoma Cells
Cimmino, F., Pezone, L., Avitabile, M., Persano, L., Vitale, M., Sassi, M., Bresolin, S., Serafin, V., Zambrano, N., Scaloni, A., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00457 · Cited by 9
Comparison of metabolite profiles in U87 glioma cells and mesenchymal stem cells
Jürchott, K., Guo, K., Catchpole, G., Feher, K., Willmitzer, L., Schichor, C., & Selbig, J. (2011) · Biosystems · doi:10.1016/j.biosystems.2011.05.005 · Cited by 9
Sonoda, Y., & Tominaga, T. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.19 · Cited by 9
Wang, Y., Ma, S., & Ruzzo, W. L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/719294 · Cited by 9
Turano, M., Vicidomini, R., Cammarota, F., D’Agostino, V., Duraturo, F., Izzo, P., & Rosa, M. D. (2023) · Biomedicines · doi:10.3390/biomedicines11051428 · Cited by 9
Multifactorial Distress, the Warburg Effect, and Respiratory and pH Imbalance in Cancer Development
Drochioiu, G. (2023) · Stresses · doi:10.3390/stresses3020036 · Cited by 10
Lichner, Z., Mac‐Way, F., & Yousef, G. M. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.08.003 · Cited by 8
The oxidoreductase p66Shc acts as tumor suppressor in BRAFV 600E‐transformed cells
Furlan, T., Khalid, S., Nguyen, A.-V., Günther, J., & Troppmair, J. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12199 · Cited by 8
Yu, Q.-K., Han, L.-T., Wu, Y., & Liu, T. (2020) · Microorganisms · doi:10.3390/microorganisms8111730 · Cited by 8
Cancer cells’ chamber of secrets: the link between micronuclei, chromothripsis and malignancy
Mcneil, T. R., Sikder, S., & Dalal, Y. (2025) · Open Biology · doi:10.1098/rsob.240388 · Cited by 7
Bioinformatics analysis and expression study of fumarate hydratase in lung cancer
Ming, Z., Jiang, M., Li, W., Fan, N., Deng, W., Zhong, Y., Zhang, Y., Zhang, Q., & Yang, S. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12127 · Cited by 7
Koch, A., Schönlebe, J., Vojvodic, A., Lotti, T., & Wollina, U. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.625 · Cited by 8
Differential Abundance of Brain Mitochondrial Proteins in Yak and Cattle: A Proteomics-Based Study
Ma, X., Zhang, Q., La, Y., Fu, D., Jiang, H., Bao, P., Wu, X., Chu, M., Guo, X., Yan, P., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.663031 · Cited by 7
Luo, C., Zhou, M., Chen, C., Li, S., Li, Q., Huang, Y., & Zhou, Z. (2022) · Nanoscale · doi:10.1039/d1nr08215a · Cited by 7
Targeting proteomics to investigate metastasis-associated mitochondrial proteins
Chou, H., & Chan, H. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9466-8 · Cited by 7
Wan, S., Wu, Y., Zhou, X., Chen, Y., An, J., Yu, X., Zhang, H., Yang, H., & Xing, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124471 · Cited by 7
Li, Y., Héroux, P., & Kyrychenko, I. (2011) · Tumor Biology · doi:10.1007/s13277-011-0262-6 · Cited by 9
Cichorek, M., Ronowska, A., Gensicka‐Kowalewska, M., Deptuła, M., Pelikant‐Małecka, I., & Dzierzbicka, K. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2776-4 · Cited by 7
Makowski, M., & Archer, K. J. (2015) · Cancer Informatics · doi:10.4137/cin.s17278 · Cited by 7
Metadata
- Authors
- King, A., Selak, M. A., & Gottlieb, E.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Gottlieb, E
- Venue
- Oncogene
- Published
- 2006-08-07
- Volume
- 25
- Issue
- 34
- Pages
- 4675-4682
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2005828644
- Semantic Scholar
- 960f2f114b8beb17db8bd6d91cd79f788b80738a
- Cited by
- 672
- References
- 61
- Citations by year
- 2026: 21 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 42 · 2021: 39 · 2020: 38 · 2019: 37 · 2018: 37 · 2017: 42 · 2016: 39 · 2015: 37 · 2014: 42 · 2013: 37 · 2012: 52
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- succinate dehydrogenase, fumarate hydratase, mitochondrial dysfunction, tumour suppressor, succinic acid, fumarate, metabolic signalling, prolyl hydroxylase inhibition, pseudohypoxia, hypoxia-inducible factor, apoptosis resistance, carcinogenesis
- MeSH terms
- Fumarate Hydratase, Humans, Mitochondria, Neoplasms, Succinate Dehydrogenase, Genes, Tumor Suppressor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
